Allurion Technologies Inc. (ALUR)

Allurion Technologies Inc. develops a weight loss platform for people who are overweight or have obesity. Its core offering is the Allurion Program, built around the Allurion Balloon, an intragastric balloon that is swallowed rather than placed through a procedure.

The program is supported by the Allurion Virtual Care Suite, which adds AI-powered remote patient monitoring, a proprietary behavior change program, and secure messaging and video telehealth. The company pairs this non-surgical device with digital tools aimed at keeping patients engaged and supported during weight loss.

Allurion is headquartered in Natick, Massachusetts. Its stated goal is to change how obesity is treated and to make weight management options more accessible.